Quest Diagnostics All other operating segments — Operating Income (Loss) decreased by 12.5% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.5%, from $8.00M to $7.00M. Over 4 years (FY 2021 to FY 2025), All other operating segments — Operating Income (Loss) shows an upward trend with a 2.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher income indicates improved operational efficiency or higher margins within these secondary units, whereas losses may signal underperformance or high overhead.
This metric measures the profitability of the company's non-core operating segments after accounting for direct operatin...
Comparable to operating income reported for 'Other' segments in peer diagnostic or laboratory services companies.
dgx_segment_all_other_operating_segments_operating_income_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $8.00M | $3.00M | $7.00M | $6.00M | $3.00M | $4.00M | $8.00M | $10.00M | $8.00M | $8.00M | $9.00M | $8.00M | $6.00M | $10.00M | $8.00M | $7.00M | $9.00M | $8.00M | $7.00M |
| QoQ Change | — | -11.1% | -62.5% | +133.3% | -14.3% | -50.0% | +33.3% | +100.0% | +25.0% | -20.0% | +0.0% | +12.5% | -11.1% | -25.0% | +66.7% | -20.0% | -12.5% | +28.6% | -11.1% | -12.5% |
| YoY Change | — | — | — | — | -33.3% | -62.5% | +33.3% | +14.3% | +66.7% | +166.7% | +100.0% | +12.5% | -20.0% | -25.0% | +25.0% | -11.1% | -12.5% | +50.0% | -20.0% | -12.5% |